Bayer
Tracked across 34 events · 717 articles · First seen Oct 06, 2025 · Last active Aug 20, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Impact: Bayer Group is consolidating its U.S. glyphosate business into Ruveon LLC to optimize operations and enhance focus on innovation and profitability within its Crop Science division.
Jul 01, 2026 · 6 articles
Business
Impact: Bayer has agreed to a proposed $7.25 billion settlement to resolve thousands of lawsuits alleging its Roundup weedkiller causes cancer, aiming to reduce litigation uncertainty and financial strain. This settlement is crucial for Bayer's financial survival and ability to continue selling Roundup in agricultural markets.
Feb 17, 2026 · 10 articles
Business
Impact: Bayer completed the acquisition of TherapeuticsMD, strengthening its pharmaceutical pipeline and ophthalmology expertise. This acquisition gives Bayer full rights to PER-001 intravitreal implant.
Jun 17, 2026 · 7 articles
Business
Impact: Bayer>>> appointed Matt Reinhardt>>> as President of its Radiology business, aiming to drive innovation and growth in a key division. This strategic move is expected to strengthen Bayer>>>'s position in medical imaging solutions.
Jun 09, 2026 · 6 articles
Business
Impact: Bayer announced leadership changes within its Consumer Health division to accelerate growth and strengthen commercial execution, aiming to enhance its 'Road to Billions' strategy.
Jun 08, 2026 · 7 articles
Business
Impact: Bayer forms its first academic medical center alliance for clinical trials, aiming to accelerate drug development and expand patient access, which could enhance its pipeline and reputation.
Jul 07, 2026 · 7 articles
Regulatory
Impact: Bayer is the primary beneficiary; the ruling shields it from thousands of failure-to-warn lawsuits, reducing litigation risk and boosting investor confidence. Shares rose ~18%.
Jun 25, 2026 · 133 articles
Regulatory
Canada — Health Canada has expanded the market authorization of Bayer's elinzanetant (brand name Lynkuet) to treat moderate to severe hot flashes and night sweats in breast cancer patients. The drug was first approved in…
Impact: Manufacturer of elinzanetant; the approval expands its market and potential revenue, though public funding in Canada is pending.
Aug 17, 2026 · 6 articles
Business
Impact: Bayer is partnering with Natur-Tec India Private Limited to jointly develop biodegradable and compostable seedling cups, contributing its crop science capabilities to advance sustainable agriculture.
Jun 16, 2026 · 7 articles
Business
Impact: Bayer invested in Bicara Therapeutics' $180 million financing, supporting the development of deupirfenidone.
Jul 02, 2026 · 6 articles
Business
Impact: Bayer's investment arm Bayer led the round, aligning with Bayer's sustainability objectives and potentially enhancing its agricultural technology portfolio.
Jul 14, 2026 · 6 articles
Tech
Impact: Bayer's subsidiary, MiNK Therapeutics, is exploring approaches related to regulatory T cells, showing the company's involvement in this emerging field.
Oct 06, 2025 · 6 articles
Business
Multiple market research reports project significant growth in the global hematology analyzers and reagents market over the next several years. MarketsandMarkets forecasts growth from USD 7.57 billion in 2026 to USD 10.33 billion by 2031,…
Impact: Mentioned as player; limited direct impact.
Jul 08, 2026 · 6 articles
Regulatory
Impact: Bayer is reviewing its options regarding the United States — Medicaid pilot program, having missed the application deadline.
Apr 20, 2026 · 6 articles
Business
Impact: Bayer is a pharmaceutical company that participates in the OpenFold consortium, benefiting from access to AI-enabled tools for drug discovery.
Jun 10, 2026 · 9 articles
Domestic
Impact: Bayer is a partner supporting the broader AgriConnect initiative led by the World Bank Group.
Jun 04, 2026 · 6 articles
Regulatory
Impact: Bayer supported Gilead's appeal as an amicus, benefiting from the ruling that limits drugmakers' liability.
Aug 03, 2026 · 6 articles
Tech
Impact: Bayer>>> is mentioned as a competitor with its ARPI drug Nubeqa, indicating potential market competition with Johnson & Johnson>>>'s Apalutamide>>>.
May 31, 2026 · 6 articles
Business
Impact: Bayer leverages Databricks for AI and data analytics, benefiting from platform advancements.
Jul 17, 2026 · 12 articles
Tech
Oncoinvent, a biotech company developing Radspherin, an alpha radiopharmaceutical for treating peritoneal metastases, announced the publication of clinical dosimetry data in the The Journal of Nuclear Medicine. The publication, titled 'Normal Tissue Dosimetry of Intraperitoneal…
Impact: Bayer is mentioned as the acquirer of Algeta and Xofigo, providing background on Oncoinvent's founders. No direct impact on Bayer.
Aug 11, 2026 · 6 articles
International
The Strait of Hormuz, a critical waterway for global oil and LNG shipments, remains effectively closed following the US-Israel war on Iran that began on February 28. Iran has asserted control over the strait and…
Impact: Bayer fell, minor impact.
Jul 28, 2026 · 318 articles
+ 4 more events
View on Dashboard
100
Canada — Health Canada authorized BayerHealth Canada approves...
80
Bayer conductedHealth Canada approves...
ERGEN INTELLIGENCE
Track Bayer live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard